Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

Oncopia Therapeutics

BET and MDM2 degrader technologies
(2018)

Optofluidic Bioassay

Improving the conventional ELISA test workflow with disposable microfluidic 96-well plates that significantly decrease total assay time and significantly reduce both sample size and reagent consumption.
(2018)

Parabricks

Parabricks uses high-performance computing techniques to reduce secondary genomics sequencing analysis time from days to one hour.
(2018)

Phenomics Heatlh

Precision clinical treatment support products and services based on advanced pharmacoepigenomics
(2018)

PreDxion Bio

PreDxion Bio's technology is a patent-pending diagnostic device that gives doctors the information they need to precisely tailor treatments to a specific patient's immune response. The idea is to make precision care more available to people in intensive care.
(2018)

RITMO

Applying artificial intelligence, data science, and operations research to design and operate a new generation of on-demand urban transit systems
(2018)

Rydberg Technologies

Quantum sensing, measurement, and imaging devices for radio-frequency, microwave, and terahertz electric fields.
(2018)

SEMA Labs

Automated code maintenance through smart systems
(2018)

STEL Technologies

Cell-Generated Ligament Grafts for All Natural ACL Replacement
(2018)

WhyFit

Corporate wellness program
(2018)

ATGC

Rabbit platform for drug discovery
(2017)

Brio

Brio develops and commercializes intelligent, intuitive, intubation devices for the insertion of endotracheal breathing tubes.
(2017)

EVOQ

Breakthrough treatment for autoimmune diseases.
(2017)

G-HMRC

The G-HMRC will provide health risk assessment (HRA) services and products as a multi-channel intelligent communication tool for health management decision support and will continue to advance our offerings through ongoing research and technology developments.
(2017)

Give and Take

Smart tools for building engagement and social capital for corporations and large organizations.
(2017)

Neurable

Brain computer interface technology to control physical and digital objects with brain activity.
(2017)

NyNex

Small molecule deubiquitinase inhibitors (DUBs) for cancer treatment.
(2017)

Ripple

Web-based software that facilitates the recruitment and management of research participants for clinical trials.
(2017)
1 7 8 9 10 11 12 13 21